...
首页> 外文期刊>Reviews in the neurosciences >Modulatory effects following subchronic stimulation of brain 5-HT7-R system in mice and rats.
【24h】

Modulatory effects following subchronic stimulation of brain 5-HT7-R system in mice and rats.

机译:亚慢性刺激小鼠和大鼠大脑5-HT7-R系统后的调节作用。

获取原文
获取原文并翻译 | 示例
           

摘要

The serotonin receptor 7 (5-HT7-R) plays important functional roles in learning and memory, in regulation of mood and circadian rhythmicity. LP-211 is a new selective agonist, belonging to 1-arylpiperazine category. We report studies aimed to evaluate the modulatory effect of a subchronic regimen on behavioral/molecular parameters. At low dose [0.25 mg/kg intraperitoneally (i.p.)], LP-211 induced a 6-h anticipated wake up in adult mice (with no temporal landmark by constant light), acting as nonphotic stimulus for 'internal clock' resetting. In standard 12:12-h light/dark cycle, a subchronic effect (5-6 days at 0.25 mg/kg, once per day) was observed: delayed wake up, reduced peak of locomotor activity and no evidence for brain cellular proliferation after ex vivo analysis. Other studies in rats were aimed to investigate long-term effects of developmental LP-211 administration into adulthood. Subchronic LP-211 (0.125 mg/kg i.p. once per day during the prepuberal phase) reduced l-glutamate, N-methyl-d-aspartate receptor 1 and dopamine transporter within the ventral striatum. With LP-211 (0.25 mg/kg i.p. once per day during the postpuberal phase), clear reductions were observed in the immunoreactivity of serotonin transporter and dopaminergic D2 receptors in the ventral and dorsal striatum, respectively. Subchronic LP-211 in rats and mice appears to be a suitable tool for studying the role of 5-HT7-R in sleep disorders, emotional/motivational regulations, attentive processes and executive functions.
机译:血清素受体7(5-HT7-R)在学习和记忆,调节情绪和昼夜节律方面起着重要的功能作用。 LP-211是一种新的选择性激动剂,属于1-arylpiperazine类别。我们报告旨在评估亚慢性病对行为/分子参数的调节作用的研究。在低剂量[0.25毫克/千克腹膜内(i.p.)]下,LP-211预计会在成年小鼠中唤醒6小时(在恒定光照下没有时间标志),作为“内部时钟”重置的非光刺激。在标准的12:12-h光照/黑暗周期中,观察到亚慢性效应(0.25 mg / kg,每天5-6天,每天一次):延迟醒来,运动活动峰值降低,并且没有证据表明离体分析。大鼠的其他研究旨在研究发育性LP-211给药至成年期的长期影响。亚慢性LP-211(青春期前每天腹腔一次0.125 mg / kg)在腹侧纹状体内减少了L-谷氨酸,N-甲基-d-天冬氨酸受体1和多巴胺转运蛋白。使用LP-211(青春期后每天一次,每次0.25 mg / kg腹腔注射),在腹侧和背侧纹状体中血清素转运蛋白和多巴胺能D2受体的免疫反应性分别明显降低。大鼠和小鼠中的亚慢性LP-211似乎是研究5-HT7-R在睡眠障碍,情绪/动机调节,注意过程和执行功能中的作用的合适工具。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号